Author’s reply to the letter to the editor by Wang: Statistical inconsistencies in a TriNetX study of semaglutide and gliflozins in patients with obesity and type 2 diabetes
Therapeutic Advances in Endocrinology and Metabolism · 2026-11 · 19
DOI: 10.1177/20420188261508209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Endocrinology and Metabolism, online erschienen am 11.11.2026. Verfasst von Jo-Ching Chen und 5 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, J., Liu, K., Huang, Y., Meyerowitz-Katz, G., Tsai, T., & Su, P. (2026). Author’s reply to the letter to the editor by Wang: Statistical inconsistencies in a TriNetX study of semaglutide and gliflozins in patients with obesity and type 2 diabetes. Therapeutic Advances in Endocrinology and Metabolism, 19. https://doi.org/10.1177/20420188261508209
Vancouver
Chen J, Liu K, Huang Y, Meyerowitz-Katz G, Tsai T, Su P. Author’s reply to the letter to the editor by Wang: Statistical inconsistencies in a TriNetX study of semaglutide and gliflozins in patients with obesity and type 2 diabetes. Therapeutic Advances in Endocrinology and Metabolism. 2026;19. doi:10.1177/20420188261508209
BibTeX
@article{Chen2026,
author = {Chen, Jo-Ching and Liu, Kai-Wen and Huang, Yu-Nan and Meyerowitz-Katz, Gideon and Tsai, Tsung-Hsun and Su, Pen-Hua},
title = {Author’s reply to the letter to the editor by Wang: Statistical inconsistencies in a TriNetX study of semaglutide and gliflozins in patients with obesity and type 2 diabetes},
journal = {Therapeutic Advances in Endocrinology and Metabolism},
year = {2026},
volume = {19},
doi = {10.1177/20420188261508209}
}
EUVIMED